Supplementary Tables and Figures S1 from Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2− Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial
Authors:
- Adrienne G. WaksAWAdrienne G. Waks
- Elia SeguiESElia Segui
- Tianyu LiTLTianyu Li
- Marla Lipsyc-SharfMLMarla Lipsyc-Sharf
- Eliza KallfelzEKEliza Kallfelz
- Molly DiLulloMDMolly DiLullo
- Ashka PatelAPAshka Patel
- Tasnim RahmanTRTasnim Rahman
- Katherine JunkinsKJKatherine Junkins
- Hajer RaheeHRHajer Rahee
- Anna Mae FreyAFAnna Mae Frey
- Emma KellyEKEmma Kelly
Open Access
- 1 October 2026
- other
- Published by American Association for Cancer Research (AACR)